General Facts and Information. Stop TB Partnership. (2016)

immage

TB is one of the world's top health challenges. More than 2.4 billion people, equal to a one third of the world's population are infected with TB. 3.5 people are either not diagnosed. The proportions of missed cases remains the same each year. Many of those missed will either die, follow some unknown treatment but most will continue to infect others.

 


Keywords: HIV/AIDS, MDR-TB, diagnosis, new cases, deaths

 

 

Download Infographic

Regional Framework for Action on Implementation of the End TB Strategy in the Western Pacific, 2016-2020. WHO, Regional Office for the Western Pacific. (2016)

immage

In 2014, the Sixty-seventh World Health Assembly endorsed the Global strategy and targets for tuberculosis prevention, care and control after 2015, also known as The End TB Strategy. The strategy aims to “end the global TB epidemic” by 2035, bringing the level of disease burden in the whole world down to the level seen now in countries with the lowest TB burden. Within the scope of this 20-year time span, this regional framework focuses on the implementation of The End TB Strategy in the coming five years.

 

Keywords: TB, HIV, treatment, drug-resistant, response

 

Download Publication

Meeting Report: Report of the Global Consultation on the Programmatic Management of Latent Tuberculosis Infection. Hamada Y and Getahun H. (2016)

immage

The Global TB Programme of WHO in collaboration with the Republic of Korea’s Centers for Disease Control and Prevention and International Tuberculosis Research Center organized a global consultation on the management of latent tuberculosis infection (LTBI) that was held during April 27–28, 2016, in Seoul, Republic of Korea. The objective of the meeting was to present and discuss challenges to, opportunities for, and best practices on the programmatic management of LTBI, and to consider recommendations to facilitate its implementation in both high-burden and low-burden countries.

 


Keywords: TB infection, children, prevention, treatment, monitoring and evaluation

Download Publication

The Use of Delamanid in the Treatment of Multidrug-resistant Tuberculosis in Children and Adolescents. WHO. (2016)

immage

The use of delamanid in the treatment of MDR-TB was recommended by the World Health Organization (WHO) in 2014. However, due to the lack of evidence on the use of delamanid in the paediatric populations, these interim policy recommendations were limited to adult MDR-TB patients under very strict conditions. In view of recent data on the use of delamanid in children diagnosed with MDR-TB, WHO convened an independent, multidisciplinary, international expert panel to assess new data and develop an addendum to the 2014 interim guidance on delamanid, with specific recommendations to paediatric MDR-TB patients. 


Keywords: TB, child, adolescent, treatment, guideline 

 

Download Publication

 

TB Financing in 2014 Country Profile: Afghanistan. Stop TB Partnership. (2016)

immage

TB is curable, but 37,000 people die every year from this airborne disease in our region - that’s almost five deaths every hour. Despite the shocking statistics and the heart-wrenching stories, international financial support for TB programmes in the European region is declining. These factsheets give a snapshot view of the TB burden in the countries.

 


Keywords: AIDS, TB, Afghanistan, funding, domestic, international

 

Download Infographic

Toolkit for Developing a National TB Research Plan. WHO. (2015)

immage

Tuberculosis (TB) remains an important global health problem. Although a number of important advances have been made to control TB in the past decade, an estimated 10.4 million people fell ill with TB and 1.8 million died from the disease in 2015. WHO’s Global TB Programme has identified research and innovation as one of the three essential pillars to end TB as a public health threat by 2030. This document provides the structure and tools that enable the necessary actions to be taken to address country-specific TB challenges and ensure that national response activities are supported by evidence to the fullest extent possible.

 

This document describes how to develop a country-specific approach to utilizing research and innovation to strengthen and improve TB care and control. It provides a series of tools for developing and implementing a national TB research plan that will help in leveraging individual country action to address the global TB burden. These tools will assist a country’s national TB control programme or its equivalent to develop an effective national TB research plan through a coherent step-by-step process.


Keywords: TB, HIV, prevention, control, research, strategy

 

Download Publication

TB Financing in 2014 Country Profile: Bangladesh. Stop TB Partnership. (2016)

immage

TB is curable, but 37,000 people die every year from this airborne disease in our region - that’s almost five deaths every hour. Despite the shocking statistics and the heart-wrenching stories, international financial support for TB programmes in the European region is declining. These factsheets give a snapshot view of the TB burden in the countries.


Keywords: AIDS, TB, Bangladesh, funding, domestic, international

 

Download Infographic

Bending the Curve - TB in the WHO South-East Asia Region. WHO, Regional Office for South-East Asia. (2016)

immage

In May 2014, the World Health Assembly in its resolution WHA67.1 adopted the Global Strategy and Targets for Tuberculosis Prevention, Care and Control after 2015 based on a bold vision of a world without tuberculosis and targets for ending the global tuberculosis epidemic and elimination of associated catastrophic costs for tuberculosis affected households. The three pillars of the strategy include: integrated, patient-centred care and prevention; bold policies and supportive systems; and intensified research and innovation.

 

Keywords: TB, HIV, health systems, drug-resistant, care, control

 

Download Publication

National Strategic Plan for Tuberculosis 2016-2020. National Tuberculosis Programme, Myanmar. (2016)

immage

The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality TB prevention and care service to the entire population, as an integral part of the country's move toward Universal Health Coverage. Between 1990 and 2015, Myanmar reduced the prevalence of TB by 50%, meeting the targets set by the Millennium Development Goals. Going forward, the country aims to further accelerate the rate decline.

 


Keywords: TB, HIV, prevention, care, drug-resistant

 

 

Download Publication

WHO Treatment Guidelines for Drug-resistant Tuberculosis, 2016 Update. WHO. (2016)

immage

The scope of the WHO treatment guidelines for drug-resistant tuberculosis, 2016 update thus differed from the one that guided the previous update of the WHO policy recommendations on the programmatic management of drug-resistant TB in 2011. It did not cover aspects of policy guidance on the programmatic management of drug-resistant TB that were of lesser priority or for which no new evidence has emerged since the 2011 revision. These included questions relating to the use of rapid diagnostics for RR-TB, the monitoring of response to treatment, the duration of longer (“conventional”) MDR-TB regimens, the delay in starting antiretroviral therapy in MDR-TB patients with human immunodeficiency virus (HIV) and models of care. 


Keywords: TB, drug-resistant, guideline, treatment

 

Download Publication

Pages

database
Highlighted publications
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Monitoring_2018.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events